Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Haematology
|
August 11, 2021
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM)
Dante Pennipede, Ghulam Rehman Mohyuddin, Ryan Hawkins, et al.
European Journal of Haematology
|
July 10, 2022
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination
Al-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
September 20, 2024
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation
Othman S Akhtar, Shanze Arshad, Qinghua Lian, et al.
Blood Cancer Journal
|
January 25, 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, et al.
British Journal of Haematology
|
October 13, 2024
Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
Stephanie Yohay, Temitope Oloyede, Soyoung Kim, et al.
Blood Neoplasia
|
June 24, 2025
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma
Amrita Y Krishnan, Krina K Patel, Meera Mohan, et al.
Blood Advances
|
July 21, 2025
IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels
Rahul Banerjee, Meera Mohan, Kai Rejeski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 29, 2019
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes
Meera Mohan, Sandra Susanibar-Adaniya, Amy Buros, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 20, 2022
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma
Tahani Atieh, Shebli Atrash, Nausheen Ahmed, et al.
Bone
|
February 8, 2021
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience
Meera Mohan, Manoj Kumar, Rohan Samant, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Haematology
|
August 11, 2021
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM)
Dante Pennipede, Ghulam Rehman Mohyuddin, Ryan Hawkins, et al.
European Journal of Haematology
|
July 10, 2022
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination
Al-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
September 20, 2024
Comparison of Thiotepa-based Conditioning Regimens for Older Adults with Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplantation
Othman S Akhtar, Shanze Arshad, Qinghua Lian, et al.
Blood Cancer Journal
|
January 25, 2024
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, et al.
British Journal of Haematology
|
October 13, 2024
Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
Stephanie Yohay, Temitope Oloyede, Soyoung Kim, et al.
Blood Neoplasia
|
June 24, 2025
Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma
Amrita Y Krishnan, Krina K Patel, Meera Mohan, et al.
Blood Advances
|
July 21, 2025
IVIG prophylaxis should be initiated following bispecific antibody therapy in multiple myeloma regardless of IgG levels
Rahul Banerjee, Meera Mohan, Kai Rejeski, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
January 29, 2019
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes
Meera Mohan, Sandra Susanibar-Adaniya, Amy Buros, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 20, 2022
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma
Tahani Atieh, Shebli Atrash, Nausheen Ahmed, et al.
Bone
|
February 8, 2021
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience
Meera Mohan, Manoj Kumar, Rohan Samant, et al.
Page
of 7